• No results found

advanced lung cancer inflammation index

Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta analysis

Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta analysis

... in cancer patients is the result of the chronic systemic inflammatory response and often indicates a poor outcome for cancer patients [17, ...of cancer cachexia syndrome and is associated with poor ...

9

Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy

<p>Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy</p>

... workup was as previously reported elsewhere. 30,31 For each patient, the gross tumor volume included the primary tumor and involved lymph nodes apparent on contrast- enhanced CT (short axis ≥ 1.0 cm) and/or PET images, ...

9

Neutrophil Lymphocyte Ratio (NLR) in Patients with Lung Cancer - An Index of Cancer Related Systemic Inflammation

Neutrophil Lymphocyte Ratio (NLR) in Patients with Lung Cancer - An Index of Cancer Related Systemic Inflammation

... of inflammation and aberrant repair (2) Inflammation is the natural response of body to any sort of injury(pathogen, allergen, toxins, products from tissue damage),and is mediated by the innate and adaptive ...

6

Inflammation based prognostic scores and nutritional prognostic index in patients with locally advanced unresectable colorectal cancer

Inflammation based prognostic scores and nutritional prognostic index in patients with locally advanced unresectable colorectal cancer

... ng/mL, respectively. Fifty-three patients died of progressive disease during the follow-up period and the remaining eight were alive at May 2014. Only one patient under- went complete resection of both distant metastatic ...

5

TLR3 absence confers increased survival with improved macrophage activity against pneumonia

TLR3 absence confers increased survival with improved macrophage activity against pneumonia

... 3). Lung contusion (LC) is the prima- ry cause of mortality following blunt chest trauma and blast explosions, while being an independent risk factor for the development of acute respiratory distress syndrome and ...

28

Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients

Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients

... assess cancer self-perceived discrimination since there has been only a very few scales specifically evaluating stigma and ...Cataldo Lung Cancer Stigma Scale (CLCSS) with 31 items and four subscales ...

9

Radiation-induced esophagitis in lung cancer

Radiation-induced esophagitis in lung cancer

... Abstract: Radiation-induced esophagitis is the most common local acute toxicity of radio- therapy (RT) delivered for the curative or palliative intent treatment of lung cancer. Although concurrent ...

9

Salvage treatment with apatinib for advanced non-small-cell lung cancer

Salvage treatment with apatinib for advanced non-small-cell lung cancer

... Patients with advanced NSCLC who received apatinib as third-line or further treatment between 2014 and 2015 were recruited. Inclusion criteria were 1) histological or cytological diagnosis of NSCLC according to ...

5

Emerging challenges of advanced squamous cell lung cancer

Emerging challenges of advanced squamous cell lung cancer

... Lung cancer is the leading cause of cancer- related mortality ...cell lung cancer (NSCLC) accounts for ∼85% of new diagnoses and about 20 – 30% NSCLC cases are squamous cell lung ...

8

Gemcitabine for the treatment of advanced nonsmall cell lung cancer

Gemcitabine for the treatment of advanced nonsmall cell lung cancer

... The similar activity of new generation platinum-based regimens observed in phase III trials prompted investigators to analyze cost-effectiveness parameters to better identify an optimal combination for the first-line ...

9

Refining the treatment of advanced nonsmall cell lung cancer

Refining the treatment of advanced nonsmall cell lung cancer

... cell lung cancer (NSCLC) is a debilitating and deadly disease with virtually no chance for long-term ...that lung cancer is a very complex ...of advanced NSCLC including the use of ...

14

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

... Anatomic tumour factors often play a role in the outcome of patients with ABC, as biliary obstruction is a common complication, and deranged liver function is often encountered. Due to the highly experimental nature of ...

7

Gefitinib for advanced non small cell lung cancer

Gefitinib for advanced non small cell lung cancer

... interstitial lung disease (patients with chronic, stable, radio- graphic changes who are asymptomatic need not be ...the lung must be completed at least 4 weeks before day 1 with no persistence of any ...

270

Systemic immune&ndash;inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

Systemic immune&ndash;inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

... gastric cancer were confirmed in accordance with pathologic evidence; 2) Eastern Cooperative Oncology Group perfor- mance status between 0 and 2 and Karnofsky performance status ≥ 80; 3) life expectancy ≥ 3 ...

19

Video assisted thoracic surgery vs. thoracotomy for locally advanced lung squamous cell carcinoma after neoadjuvant chemotherapy

Video assisted thoracic surgery vs. thoracotomy for locally advanced lung squamous cell carcinoma after neoadjuvant chemotherapy

... stage lung can- cer, but in recent years it has been carried out by some experienced thoracic surgeons in LANSCLC with satis- factory outcome [10, ...on Cancer (AJCC 8) staging ...

9

NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score

<p>NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score</p>

... and advanced NSCLC is often ...with cancer, promotes the growth and spread of cancer, and activates oncogenic ...with cancer, such as elevated circulating albumin concentrations, absolute ...

11

A pilot double blind, randomized, placebo controlled trial of curcumin/bioperine for lung cancer chemoprevention in patients with chronic obstructive pulmonary disease

A pilot double blind, randomized, placebo controlled trial of curcumin/bioperine for lung cancer chemoprevention in patients with chronic obstructive pulmonary disease

... lates inflammation, angiogenesis, and tumor cell survival, invasion, and metastasis ...in cancer patients ...with advanced colo- rectal cancer refractory to standard treatment, study sub- ...

8

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study

... systemic inflammation or lung ...evaluate lung cancer risk in patients at high risk for developing the ...of lung cancer in the ...

11

Bevacizumab Beyond Progression in  Metastatic NSCLC

Bevacizumab Beyond Progression in Metastatic NSCLC

... with advanced stage non–small cell lung cancer or colorectal cancer who receive chemotherapy plus the anti-VEGF monoclonal antibody (mAb) bevacizumab is relatively short, averaging less than ...

6

Afatinib treatment in advanced non-small cell lung cancer

Afatinib treatment in advanced non-small cell lung cancer

... of advanced non-small cell lung cancer (NSCLC), prognosis for these patients remains ...most advanced of these agents in clinical ...in advanced NSCLC. The LUX-Lung trials ...

11

Show all 10000 documents...

Related subjects